1 The effect of a combination of chlorpropamide and chlorothiazide in Brattleboro rats with hereditary hypothalamic diabetes insipidus (DI) treated with low doses of vasopressin (Pitressin tannate in oil) was investigated with particular reference to the time course of response from the initiation of treatment. 2 Analysis of the relationship between water intake and body weight indicated no real correlation and body weight accounted for only 4.4% of the variation in water intake. It was therefore decided to use whole body responses as the index in preference to the response per unit body weight. 3 The daily administration of 5 mg chlorpropamide combined with chlorothiazide in the drinking water (4 mg/l) to Pitressin-treated DI rats potentiated the response to small doses of vasopressin (25 and 50 mu Pitressin/24 hours). Water intake was reduced by the drug combination by an average of 12.35 ml/24 h, but only on the second day of treatment was the decrease of any real magnitude (30 ml/24 h but otherwise 9 ml/24 h or less). Analysis of urine volume measurements gave similar results to those obtained for water intake and the potency ratio measured in terms of free water clearance was 1.26 (agreeing closely with the ratio for water intake which was 1.24). 4 A reduction in the solute excretion was observed only in those DI rats treated with the higher dose of Pitressin (50 mu/24 h) combined with the two drugs. 5 Possible reasons for the discrepancy between the effect of the combination of chlorpropamide and chlorathiazide on water metabolism in the DI rat and the DI patient are discussed.
Introduction
In studies on the effect of chlorpropamide in Brattleboro rats with hereditary diabetes insipidus (DI) it has been shown that the drug appears to potentiate the antidiuresis induced by small amounts of exogenous vasopressin (Berndt, Miller, Kettyle & Valtin, 1970; Miller & Moses, 1970 ). Laycock, Lee & Lewis (1974) recently showed that while the potentiating effect of chlorpropamide did exist in these experimental animals treated with a small amount of vasopressin (25 mu Pitressin/24 h) this effect was minimal and could not be compared with the sometimes dramatic reductions in water excretion observed in many patients with diabetes insipidus (e.g. Arduino, Ferraz & Rodriguez, 1966; Wales & Fraser, 1971) .
Chlorothiazide, on the other hand, has been shown to have an antidiuretic effect independent of vasopressin in an uncontrolled trial on patients with DI (Crawford, Kennedy & Hill, 1960) , rats with experimental DI (Skadhauge, 1966) and in Brattleboro DI rats (Laycock, 1973) . In the present study, the effect of a combination of the two drugs, chlorpropamide and chlorothiazide, has been measured in the Brattleboro DI rat treated with low doses of Pitressin to examine whether the antidiuresis is significantly improved by such a therapy. In addition, the time course of the changes in water intake, urine volume and solute output were studied, in order to determine the possible mechanism (or mechanisms) involved in potentiating the actions of the antidiuretic hormone, vasopressin.
Methods
The general methodology used for this experiment has been described by Laycock et al. (1974 The responses to these doses were known to be submaximal (Laycock & Williams, 1973 (Lewis, 1974 Figure 2) but only on the second day was it of any real magnitude (30 ml/24 h but otherwise 9 ml/24 h or less).
The effect of the drug combination on urine and solute outputs Values for the urine and solute output were available for the eight animals in groups A and B and analysis of the urine output gave similar results to those obtained from water intake measurements (Table 2) , the daily urine volume being on average 22.7 ml less than the daily water intake. The daily solute output was calculated from the known urine volumes and urine osmolalities. The effect of the four treatments (S1, S2, TI and T2) upon the solute excretion of DI rats is shown in Figure 3 . A considerable degree of interaction exists and there is therefore no evidence for similarity between the treatment responses. On the basis of the results, only treatment T2 had any material effect on the solute output, eliminating the increase on day 2 (Figure 3b ) and yielding a more progressive reduction in solute excretion over the 4 days (Figure 3a) than the other three treatments.
The relationship between urine volume and solute excretion is shown in Figure 4a . The insertion of an iso-osmotic line with a slope equal to the reciprocal of 0.3 mosmol/kg (assuming a rat plasma osmolality of 300 mosmol/kg) permitted rapid graphical determination of the response in terms of free-water clearance, thus avoiding an otherwise tedious calculation. The vertical distance from the zero free-water clearance line in Figure 4b for the four treatments is equal to the vertical distance from the iso-osmotic line in Figure  4a . The potency ratio for this assay is 1.26. 
Discussion
In studies upon patients suffering from diabetes insipidus, both chlorpropamide and various thiazides have been shown to exert an antidiuretic effect. Webster & Bain (1970) with doses generally administered to DI patients (250-500 mg/24 h) when calculated on a surface-area ratio basis. The quantity of chlorothiazide ingested by each rat (average weight 220 g) daily was of the order of 0.5 mg/24 h, which dose using the same surfacearea ratio would correspond to some 20 mg/24 h to an average DI patient weighing some 70 kg. Such a dose of chlorothiazide would be unlikely to have any direct antidiuretic effect in treating a patient with DI, on its own, so that it was hoped that if it also had an antidiuretic effect via the chlorpropamide-Pitressin system, such an effect might be detectable in the present experiment. However, the potentiation of the vasopressin-induced antidiuresis by the drug combination was shown to be significant, but surprisingly small when compared to the clinically relevant effect observed in many DI patients. The administration of the two drugs chlorpropamide and chlorothiazide with 50 mu Pitressin/24 h (treatment T2) no longer produced an increased solute output on any of the four days of treatment but gave a progressive reduction in output over the four days.
A response expressed in terms of free water clearance gives a very similar overall potency ratio (1.26 against 1.24 for water intake) but with slightly .__ I Oo -1 more evidence of interaction between the two treatments (shown by the slight convergence of the response lines). On this basis, water intake is the preferred response variable for bioassay.
Another feature of interest concerned the daily trend of the drug-effect, most clearly shown for the water intake measurements (Figure 2) . The drug effect was present on all four days of treatment, but only on the second day of treatment was it of real importance. Since the effect due to the vasopressin alone increased to reach a maximum on the third or fourth day of treatment, these time trends could indicate that the combination of drugs might increase the velocity with which the concentrating ability of the kidney is stimulated by the action of vasopressin. One possible mechanism could be to increase the medullary interstitial fluid concentration which is a prerequisite for the maintenance of the countercurrent multiplier loop.
To conclude, the administration of a combination of chlorpropamide and chlorothiazide in the present doses to Brattleboro DI rats treated with small doses of Pitressin is insufficient to restore their water balance to levels which are comparable to those observed in normal rats. This observation differs from the reported extremely successful effect of comparable doses of these drugs in DI patients (e.g. Webster & Bain, 1970) . However, there is evidence of a dose-dependent action of vasopressin on solute excretion in these experimental animals which is modified by combination with the other drugs. Since the possibility of a renal defect in the Brattleboro DI rat cannot be discounted, further studies using this experimental model are necessary. 
